{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:55:56Z","timestamp":1791251756770,"version":"4.1.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,31]],"date-time":"2012-12-31T00:00:00Z","timestamp":1356912000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0052984","type":"journal-article","created":{"date-parts":[[2012,12,31]],"date-time":"2012-12-31T17:23:25Z","timestamp":1356974605000},"page":"e52984","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":63,"title":["EZH2 Promotes Malignant Behaviors via Cell Cycle Dysregulation and Its mRNA Level Associates with Prognosis of Patient with Non-Small Cell Lung Cancer"],"prefix":"10.1371","volume":"7","author":[{"given":"Wei","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel de Oliveira","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Saintigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghui","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwen","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hening","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,12,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"R Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Siegel R, Desantis C, Virgo K, Stein K, Mariotto A, <etal>et al<\/etal>. (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin doi:10.3322\/caac.21149, in Press.","DOI":"10.3322\/caac.21149"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/modpathol.2011.46","article-title":"Genetic and epigenetic changes in lung carcinoma and their clinical implications","volume":"24","author":"J Wen","year":"2011","journal-title":"Mod Pathol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0168-9525(93)90209-Z","article-title":"The multistep nature of cancer","volume":"9","author":"B Vogelstein","year":"1993","journal-title":"Trends Genet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/JTO.0b013e3181a4b8fb","article-title":"Prognostic and predictive markers of benefit from adjuvant chemotherapy in early-stage non-small cell lung cancer","volume":"4","author":"AB Custodio","year":"2009","journal-title":"J Thorac Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJMe068218","article-title":"Molecular signatures of lung cancer\u2013toward personalized therapy","volume":"356","author":"RS Herbst","year":"2007","journal-title":"N Engl J Med"},{"key":"ref7","first-page":"227","article-title":"A small step towards personalized medicine for non-small cell lung cancer","volume":"8","author":"T Mok","year":"2009","journal-title":"Discov Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0169-5002(01)00341-5","article-title":"Molecular abnormalities in lung carcinogenesis and their potential clinical implications","volume":"34","author":"L Mao","year":"2001","journal-title":"Lung Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/01.JTO.0000263718.69320.4c","article-title":"A translational view of the molecular pathogenesis of lung cancer","volume":"2","author":"M Sato","year":"2007","journal-title":"J Thorac Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.gde.2004.02.001","article-title":"The functions of E(Z)\/EZH2-mediated methylation of lysine 27 in histone H3","volume":"14","author":"R Cao","year":"2004","journal-title":"Curr Opin Genet Dev"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jhep.2010.01.027","article-title":"The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem\/progenitor cells","volume":"52","author":"R Aoki","year":"2010","journal-title":"J Hepatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"9211","DOI":"10.1158\/0008-5472.CAN-09-1622","article-title":"EZH2 is essential for glioblastoma cancer stem cell maintenance","volume":"69","author":"ML Suv\u00e0","year":"2009","journal-title":"Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrg2540","article-title":"Linking DNA methylation and histone modification: patterns and paradigms","volume":"10","author":"H Cedar","year":"2009","journal-title":"Nat Rev Genet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nature04431","article-title":"The Polycomb group protein EZH2 directly controls DNA methylation","volume":"439","author":"E Vir\u00e9","year":"2006","journal-title":"Nature"},{"key":"ref15","first-page":"711","article-title":"Polycomb group protein gene silencing, non-coding RNA, stem cells, and cancer","volume":"87","author":"RS Gieni","year":"2009","journal-title":"Biochem Cell Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1158\/1078-0432.CCR-05-1533","article-title":"Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer","volume":"12","author":"K Collett","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1002\/cncr.25128","article-title":"Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance","volume":"116","author":"J Kikuchi","year":"2010","journal-title":"Cancer"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/cncr.26441","article-title":"Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer","volume":"118","author":"R Huqun, Ishikawa","year":"2012","journal-title":"Cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1002\/cncr.26575","article-title":"Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma","volume":"118","author":"W Cao","year":"2012","journal-title":"Cancer"},{"key":"ref20","first-page":"624","article-title":"The polycomb group protein EZH2 is involved in progression of prostate cancer.Nature","volume":"419","author":"S Varambally","year":"2002"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"8570","DOI":"10.1158\/1078-0432.CCR-05-1047","article-title":"Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder","volume":"11","author":"JD Raman","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1349-7006.2006.00203.x","article-title":"Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer","volume":"97","author":"Y Matsukawa","year":"2006","journal-title":"Cancer Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/labinvest.2008.52","article-title":"The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma","volume":"88","author":"M Sasaki","year":"2008","journal-title":"Lab Invest"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.humpath.2010.03.004","article-title":"Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinoma","volume":"41","author":"AD Toll","year":"2010","journal-title":"Hum Pathol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/sj.bjc.6605333","article-title":"Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis","volume":"101","author":"\u00d8 Fluge","year":"2009","journal-title":"Br J Cancer"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1016\/j.juro.2009.08.014","article-title":"Expression profile of the polycomb group protein enhancer of Zeste homologue 2 and its prognostic relevance in renal cell carcinoma","volume":"182","author":"S Hinz","year":"2009","journal-title":"J Urol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.2651","article-title":"Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia","volume":"18","author":"P Ntziachristos","year":"2012","journal-title":"Nat Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1158\/0008-5472.CAN-04-3905","article-title":"Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells","volume":"66","author":"J Zhang","year":"2006","journal-title":"Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"10647","DOI":"10.1158\/0008-5472.CAN-07-1337","article-title":"Delta DNMT3B variants regulate DNA methylation in a promoter-specific manner","volume":"67","author":"J Wang","year":"2007","journal-title":"Cancer Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ng.1068","article-title":"Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis","volume":"44","author":"P Delgado-Olgu\u00edn","year":"2012","journal-title":"Nat Genet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.molcel.2009.08.008","article-title":"Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells","volume":"36","author":"AH Juan","year":"2009","journal-title":"Mol Cell"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2353\/ajpath.2009.090042","article-title":"Targeted overexpression of EZH2 in the mammary gland disrupts ductal morphogenesis and causes epithelial hyperplasia","volume":"175","author":"X Li","year":"2009","journal-title":"Am J Pathol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1158\/1940-6207.CAPR-11-0130","article-title":"EZH2 promotes malignant phenotypes and is a predictor of oral cancer development in patients with oral leukoplakia","volume":"4","author":"W Cao","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1158\/1541-7786.MCR-09-0121","article-title":"Polycomb group protein enhancer of zeste 2 is an oncogene that promotes the neoplastic transformation of a benign prostatic epithelial cell line","volume":"7","author":"BD Karanikolas","year":"2009","journal-title":"Mol Cancer Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"11606","DOI":"10.1073\/pnas.1933744100","article-title":"EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells","volume":"100","author":"CG Kleer","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1593\/neo.04160","article-title":"Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during brnochial carcinogenesis","volume":"6","author":"RH Breuer","year":"2004","journal-title":"Neoplasia"},{"key":"ref37","first-page":"e5622","article-title":"Polycomb mediated epigenetic silencing and replication timing at the INK4a\/ARF locus during senescence.PLoS One","volume":"4","author":"H Agherbi","year":"2009"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/MCB.02019-07","article-title":"SWI\/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus","volume":"28","author":"SK Kia","year":"2008","journal-title":"Mol Cell Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2184.2003.00266.x","article-title":"The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer","volume":"36","author":"K Vermeulen","year":"2003","journal-title":"Cell Prolif"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"E65","DOI":"10.1038\/35008695","article-title":"Rb function in cell-cycle regulation and apoptosis","volume":"2","author":"JW Harbour","year":"2000","journal-title":"Nat Cell Biol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1475-2867-8-15","article-title":"Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells","volume":"8","author":"H Watanabe","year":"2008","journal-title":"Cancer Cell Int"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1158\/1541-7786.MCR-10-0511","article-title":"EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21\/CDKN1A expression","volume":"9","author":"T Fan","year":"2011","journal-title":"Mol Cancer Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1600-0463.2009.02579.x","article-title":"Enhancer of zeste homolog 2 expression is associated with tumor cell proliferation and metastasis in gastric cancer","volume":"118","author":"JH Choi","year":"2010","journal-title":"APMIS"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1182\/blood-2009-03-213496","article-title":"Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells","volume":"114","author":"W Fiskus","year":"2009","journal-title":"Blood"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"22437","DOI":"10.1074\/jbc.M501379200","article-title":"Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer","volume":"280","author":"H Chen","year":"2005","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nm.2100","article-title":"An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB","volume":"16","author":"J Min","year":"2010","journal-title":"Nat Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1476-4598-10-40","article-title":"Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer","volume":"10","author":"F Crea","year":"2011","journal-title":"Mol Cancer"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0052984","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T19:23:12Z","timestamp":1540322592000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0052984"}},"subtitle":[],"editor":[{"given":"Qing-Yi","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,31]]},"references-count":47,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0052984","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,31]]}}}